Frankfurt - Delayed Quote EUR
ACADIA Pharmaceuticals Inc. (DR6.F)
13.02
+0.26
+(2.04%)
At close: April 25 at 8:54:38 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
157,719
157,719
16,702
-114,035
-125,660
Investing Cash Flow
-30,538
-30,538
31,998
73,241
-71,102
Financing Cash Flow
6,845
6,845
25,129
8,199
18,162
End Cash Position
328,359
328,359
194,427
120,616
153,205
Income Tax Paid Supplemental Data
19,521
19,521
5,850
2,190
1,038
Capital Expenditure
-523
-523
-40,050
--
-1,122
Issuance of Capital Stock
6,845
6,845
25,129
8,199
18,162
Free Cash Flow
157,196
157,196
-23,348
-114,035
-126,782
12/31/2021 - 2/23/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IKAP.F Aurinia Pharmaceuticals Inc.
7.06
+0.97%
NKB2.F TG Therapeutics, Inc.
35.26
+2.63%
9606.HK Duality Biotherapeutics, Inc.
207.400
-7.82%
KZR Kezar Life Sciences, Inc.
4.7000
-1.05%
INZY Inozyme Pharma, Inc.
0.9842
+2.52%
MTSR Metsera, Inc.
18.53
-12.51%
ALLO Allogene Therapeutics, Inc.
1.5500
-1.27%
DNLI Denali Therapeutics Inc.
15.68
+1.23%
4147.TWO TaiMed Biologics Inc.
80.00
+0.50%
REGN Regeneron Pharmaceuticals, Inc.
602.64
+0.48%